BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹38 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹34 Cr |
What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹34 Cr |
How is Total Non-Current Liabilities of BAL PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹38 Cr | -14.36 | |
| Mar2024 | ₹45 Cr | 18.02 | |
| Mar2023 | ₹38 Cr | 4.32 | |
| Mar2022 | ₹36 Cr | 6.44 | |
| Mar2021 | ₹34 Cr | - | |
Compare Total Non-Current Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹120.1 Cr | 7.2% | 5.1% | -35.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 7.2% |
5.1% |
-35.2% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses